Publications by authors named "Ulrike Baumer"

Claim this Profile
B
Beyond obesity: metabolic status as a key driver for cardiovascular outcomes in patients undergoing invasive coronary angiography.
Eva Steinacher, Andreas Hammer, Ulrike Baumer, Felix Hofer, Niema Kazem

Eur Heart J Qual Care Clin Outcomes· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Remote assessment of coronary stenosis - a valid alternative to invasive testing for non-culprit lesions?
Ulrike Baumer, Maria-Luisa Straßmeir, Lorenz Koller, Alexander Niessner

Clin Res Cardiol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Prognostic Interplay of Heart Failure and Chronic Kidney Disease in Atrial Fibrillation - Focus on Cardiorenal Outcomes.
Ulrike Baumer, Lea Pedarnig, Andreas Hammer, Eva Steinacher, Niema Kazem

Cardiorenal Med· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Drug-coated balloon vs drug-eluting stent in de novo coronary lesions: a propensity score matched cohort study.
Ulrike Baumer, Eva Steinacher, Andreas Hammer, Niema Kazem, Felix Hofer

Clin Res Cardiol· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mid-Regional Pro-Adrenomedullin Is Associated with Adverse Cardiovascular Outcomes After Cardiac Surgery.
Ulrike Baumer, Niema Kazem, Andreas Hammer, Felix Hofer, Eva Steinacher

J Pers Med· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Routinely Available Inflammatory Biomarkers Are Not Associated With Target Lesion Revascularization After Coronary Intervention.
Eva Steinacher, Andreas Hammer, Ulrike Baumer, Felix Hofer, Niema Kazem

JACC Adv· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Soluble ST2 is associated with postoperative atrial fibrillation after cardiac surgery in postmenopausal women.
Andreas Hammer, Frieda Marka, Ulrike Baumer, Felix Hofer, Niema Kazem

Clin Chim Acta· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sex-Related Disparities in Prescription Patterns of Sodium-Glucose Cotransporter 2 Inhibitors in Patients with Type 2 Diabetes and Heart Failure.
Andreas Hammer, Felix Hofer, Niema Kazem, Lorenz Koller, Eva Steinacher, Ulrike Baumer

J Womens Health (Larchmt)· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prescribing trends of sodium-glucose cotransporter 2 inhibitors in patients with heart failure with preserved, mildly reduced and reduced ejection fraction.
Felix Hofer, Andreas Hammer, Eva Steinacher, Ulrike Baumer, Niema Kazem

Eur Heart J Cardiovasc Pharmacother· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Surgical or Percutaneous Coronary Revascularization for Heart Failure: a Focus on Symptoms and Stenosis.
Patrick Sulzgruber, Ulrike Baumer, Alexander Niessner

Cardiovasc Drugs Ther· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Impact of Preclinical High Potent P2Y Inhibitors on Decision Making at Discharge and Clinical Outcomes in Patients with Acute Coronary Syndrome.
Andreas Hammer, Mario Krammel, Patrick Aigner, Georg Pfenneberger, Sebastian Schnaubelt, Ulrike Baumer

J Clin Med· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis